#KobayashiPharmaceuticalCoLtd

Kobayashi Pharmaceutical Co., Ltd. will transition from a company with a board of auditors to a company with an audit and supervisory committee, subject to approval at the Annual General Meeting of Shareholders on March 27, 2026, to strengthen its corporate governance framework.

Regarding the four shareholder proposals at the 108th Annual General Meeting of Shareholders to be held on March 27, 2026, the Company's Board of Directors opposes all proposals and recommends shareholders to vote against them.